164 related articles for article (PubMed ID: 9302005)
1. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Cohen MA; Huband MD
J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
[No Abstract] [Full Text] [Related]
2. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized.
Bebear CM; Renaudin H; Charron A; Gruson D; Lefrancois M; Bebear C
Antimicrob Agents Chemother; 2000 Sep; 44(9):2557-60. PubMed ID: 10952617
[TBL] [Abstract][Full Text] [Related]
5. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Renaudin H; Bébéar C
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
[TBL] [Abstract][Full Text] [Related]
7. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
Ullmann U; Schubert S; Krausse R
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():33-6. PubMed ID: 10404335
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
[TBL] [Abstract][Full Text] [Related]
9. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
Duffy LB; Crabb D; Searcey K; Kempf MC
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
[TBL] [Abstract][Full Text] [Related]
10.
Waites KB; Crabb DM; Xiao L; Duffy LB
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784668
[TBL] [Abstract][Full Text] [Related]
11. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
Farkas B; Ostorházi E; Pónyai K; Tóth B; Adlan E; Párducz L; Marschalkó M; Kárpáti S; Rozgonyi F
Orv Hetil; 2011 Oct; 152(42):1698-702. PubMed ID: 21979223
[TBL] [Abstract][Full Text] [Related]
12. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
Furneri PM; Bisignano G; Cerniglia G; Nicoletti G; Cesana M; Tempera G
Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas.
Waites KB; Crabb DM; Duffy LB
Antimicrob Agents Chemother; 2003 Dec; 47(12):3973-5. PubMed ID: 14638513
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas.
Hannan PC; Woodnutt G
J Antimicrob Chemother; 2000 Mar; 45(3):367-9. PubMed ID: 10702559
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital.
Skiljevic D; Mirkov D; Vukicevic J
Indian J Dermatol Venereol Leprol; 2016; 82(1):37-41. PubMed ID: 26728808
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum.
Dósa E; Nagy E; Falk W; Szöke I; Ballies U
J Antimicrob Chemother; 1999 Apr; 43(4):575-8. PubMed ID: 10350390
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.
Waites KB; Crabb DM; Liu Y; Duffy LB
Antimicrob Agents Chemother; 2016 Dec; 60(12):7502-7504. PubMed ID: 27671057
[TBL] [Abstract][Full Text] [Related]
18. Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.
Waites KB; Duffy LB; Bébéar CM; Matlow A; Talkington DF; Kenny GE; Totten PA; Bade DJ; Zheng X; Davidson MK; Shortridge VD; Watts JL; Brown SD
J Clin Microbiol; 2012 Nov; 50(11):3542-7. PubMed ID: 22915608
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1991 Mar; 35(3):587-9. PubMed ID: 1903913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
